Pertussis toxin as an adjuvant suppresses the number and function of CD4<sup>+</sup>CD25<sup>+</sup> T regulatory cells

European Journal of Immunology - Tập 36 Số 3 - Trang 671-680 - 2006
Xin Chen1, Robin Winkler-Pickett2, Nicholas H. Carbonetti3, John R. Ortaldo2, Joost J. Oppenheim4, O. M. Zack Howard4
1Basic Research Program, SAIC-Frederick, Inc., Laboratory of Molecular Immunoregulation, National Cancer Institute-Frederick. Frederick, MD, USA
2Laboratory of Experimental Immunology , Center for Cancer Research, National Cancer Institute‐Frederick, Frederick, MD, USA
3Department of Microbiology and Immunology, University of Maryland, Medical School, Baltimore, MD, USA
4Laboratory of Molecular Immunoregulation, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, USA

Tóm tắt

AbstractWe observed a remarkable reduction in the frequency and immunosuppressive activity of splenic CD4+CD25+ T cells in C57BL/6 mice with MOG33–55‐induced experimental autoimmune encephalomyelitis (EAE). Our study revealed that pertussis toxin (PTx), one component of the immunogen used to induce murine EAE, was responsible for down‐regulating splenic CD4+CD25+ cells. Treatment of normal BALB/c mice with PTx in vivo reduced the frequency, suppressive activity and FoxP3 expression by splenic CD4+CD25+ T cells. However, PTx treatment did not alter the expression of characteristic phenotypic markers (CD45RB, CD103, GITR and CTLA‐4) and did not increase the expression of CD44 and CD69 by the residual splenic and lymph node CD4+CD25+ T cells. This property of PTx was attributable to its ADP‐ribosyltransferase activity. PTx did not inhibit suppressive activity of purified CD4+CD25+ T regulatory (Treg) cells in vitro, but did so in vivo, presumably due to an indirect effect. Although the exact molecular target of PTx that reduces Treg activity remains to be defined, our data suggests that alteration of both distribution and function of splenic immunocytes should play a role. This study concludes that an underlying cause for the immunological adjuvanticity of PTx is down‐regulation of Treg cell number and function.

Từ khóa


Tài liệu tham khảo

10.1016/S0092-8674(00)80856-9

10.4049/jimmunol.174.1.164

10.1182/blood-2003-11-3900

10.1084/jem.20040165

10.1016/j.jhep.2004.03.008

10.1182/blood-2003-07-2598

10.1084/jem.20032158

10.1084/jem.20031579

10.1186/ar1500

10.1016/S1074-7613(00)80195-8

10.1146/annurev.iy.08.040190.003051

10.1093/intimm/dxh029

10.4049/jimmunol.169.9.4712

10.1189/jlb.0604341

Moss J., 1983, Activation by thiol of the latent NAD glycohydrolase and ADP‐ribosyltransferase activities of Bordetella pertussis toxin (islet‐activating protein)., J. Biol. Chem., 258, 11879, 10.1016/S0021-9258(17)44314-6

10.4049/jimmunol.173.11.7070

10.4049/jimmunol.170.4.1728

10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B

10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H

Ryan M., 1998, Pertussis toxin potentiates Th1 and Th2 responses to co‐injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co‐stimulatory molecules B7–1, B7–2 and CD28., Int. Immunol., 10, 651, 10.1093/intimm/10.5.651

10.1189/jlb.72.5.962

10.1002/eji.200323675

10.4049/jimmunol.174.6.3352

10.1038/nri1027

10.1038/nri1435

10.1093/intimm/dxh178

10.1186/1471-2180-5-7

10.1016/j.jaut.2004.05.001

10.4049/jimmunol.169.1.117

Caspi R. R., 1988, A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens., J. Immunol., 140, 1490, 10.4049/jimmunol.140.5.1490

10.1084/jem.132.4.663

Huang K., 1989, Molecular mechanisms of lymphocyte extravasation. III. The loss of lymphocyte extravasation potential induced by pertussis toxin is not mediated via the activation of protein kinase C., J. Immunol., 143, 229, 10.4049/jimmunol.143.1.229

10.1016/0008-8749(88)90023-8

Stanley J. B., 1989, IL‐2 secretion is pertussis toxin sensitive in a T lymphocyte hybridoma., J. Immunol., 142, 3546, 10.4049/jimmunol.142.10.3546

Zumbihl R., 1995, IL‐1 stimulates a diverging signaling pathway in EL4 6.1 thymoma cells. IL‐2 release, but not IL‐2 receptor expression, is sensitive to pertussis toxin., J. Immunol., 155, 181, 10.4049/jimmunol.155.1.181

O'Neill L. A., 1992, The binding subunit of pertussis toxin inhibits IL‐1 induction of IL‐2 and prostaglandin production., J. Immunol., 148, 474, 10.4049/jimmunol.148.2.474

10.1016/0008-8749(86)90200-5

10.1038/ni904

10.1084/jem.20042276